Explore detailed information on the case number ACT_13849/2024 involving Alexion Pharmaceuticals and Samsung Bioepis Nl B.V. which was filed on 19 Mar, 2024.

Case Details

    Case Number:

    ACT_13849/2024

    Patent Number:

    Filing Date:

    19 Mar, 2024

    Proceeding Type:

    Proceeding

    Action/Application:

    Application For Provisional Measures

    Decision Date:

    26 Jun, 2024

    Plaintiffs:

    • Alexion Pharmaceuticals, Inc. Represented By Elena Hennecke

    Defendants:

    • Samsung Bioepis Nl B.V. Represented By Peter Meyer

    Judges:

    • Alima Zana
    • Rudi Goedeweeck
    • Sabine Klepsch
    • Stefan Schilling

Case Decision

    Decision Date:

    Jun 26, 2024

    Decision Document:

More cases on EP3167888B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
ACT_59173/2024Oct 31, 2024Amgen Switzerland Ag Vilniaus FilialasAlexion Pharmaceuticals
APL_40470/2024Jul 11, 2024Alexion PharmaceuticalsSamsung Bioepis Nl B.V.
APL_40553/2024Jul 11, 2024Alexion PharmaceuticalsAmgen Technology (Ireland) Unlimited Company, Amgen N.V., Amgen Gmbh, Amgen Ab, Amgen S.A.S., Amgen S.R.L., Amgen Biofarmaceutica Lda., Amgen Zdravila D.O.O.

More cases on Alexion Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
App_8339/2025Mar 6, 2025Alexion Pharmaceuticals -
App_8340/2025Mar 6, 2025Alexion Pharmaceuticals -
ORD_55359/2024Oct 9, 2024Alexion PharmaceuticalsSamsung Bioepis NL

More cases on Samsung Bioepis Nl B.V.

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_55359/2024Oct 9, 2024Alexion PharmaceuticalsSamsung Bioepis NL
ORD_42879/2024Jul 22, 2024Alexion PharmaceuticalsSamsung Bioepis NL
APL_40470/2024Jul 11, 2024Alexion PharmaceuticalsSamsung Bioepis Nl B.V.